1. Aref, Salah, El-Ghonemy, Mohamed, Shimaa, Hendawy, Abdelmabood, Suzy, Khaled, Nada. 2023. Significance of CEBPE Gene Promoter Polymorphism (Rs2239630 G > A ) Assessment in Childhood B-cell Acute Lymphoblastic Leukemia. In Journal of pediatric hematology/oncology, 45, e334-e338. doi:10.1097/MPH.0000000000002648. https://pubmed.ncbi.nlm.nih.gov/36897378/
2. Shyamsunder, Pavithra, Sankar, Haresh, Mayakonda, Anand, Madan, Vikas, Koeffler, H Phillip. 2018. CARD10, a CEBPE target involved in granulocytic differentiation. In Haematologica, 103, 1269-1277. doi:10.3324/haematol.2018.190280. https://pubmed.ncbi.nlm.nih.gov/29773596/
3. Banday, Aaqib Zaffar, Kaur, Anit, Akagi, Tadayuki, Rawat, Amit, Singh, Surjit. 2022. A Novel CEBPE Variant Causes Severe Infections and Profound Neutropenia. In Journal of clinical immunology, 42, 1434-1450. doi:10.1007/s10875-022-01304-7. https://pubmed.ncbi.nlm.nih.gov/35726044/
4. Li, Jian-Feng, Dai, Yu-Ting, Lilljebjörn, Henrik, Chen, Sai-Juan, Huang, Jin-Yan. 2018. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. In Proceedings of the National Academy of Sciences of the United States of America, 115, E11711-E11720. doi:10.1073/pnas.1814397115. https://pubmed.ncbi.nlm.nih.gov/30487223/
5. Li, Kening, Du, Yuxin, Wei, Dong-Qing, Zhang, Fang. 2019. CEBPE expression is an independent prognostic factor for acute myeloid leukemia. In Journal of translational medicine, 17, 188. doi:10.1186/s12967-019-1944-x. https://pubmed.ncbi.nlm.nih.gov/31164135/